Cargando…

G6PD: A hub for metabolic reprogramming and redox signaling in cancer

Metabolic hubs play a major role in the initiation and development of cancer. Oncogenic signaling pathways drive metabolic reprogramming and alter redox homeostasis. G6PD has potential oncogenic activity and it plays a pivotal role in cell proliferation, survival and stress responses. Aberrant activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hung-Chi, Stern, Arnold, Chiu, Daniel Tsun-Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chang Gung University 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358196/
https://www.ncbi.nlm.nih.gov/pubmed/33097441
http://dx.doi.org/10.1016/j.bj.2020.08.001
_version_ 1783737287342817280
author Yang, Hung-Chi
Stern, Arnold
Chiu, Daniel Tsun-Yee
author_facet Yang, Hung-Chi
Stern, Arnold
Chiu, Daniel Tsun-Yee
author_sort Yang, Hung-Chi
collection PubMed
description Metabolic hubs play a major role in the initiation and development of cancer. Oncogenic signaling pathways drive metabolic reprogramming and alter redox homeostasis. G6PD has potential oncogenic activity and it plays a pivotal role in cell proliferation, survival and stress responses. Aberrant activation of G6PD via metabolic reprogramming alters NADPH levels, leading to an antioxidant or a pro-oxidant environment which can either enhance DNA oxidative damage and genomic instability or initiate oncogenic signaling. Nutrient deprivation can rewire metabolism, which leads to mutations that determine a cancer cell's fate. Deregulated G6PD status and oxidative stress form a vicious cycle, which paves the way for cancer progression. This review aims to update and focus the potential role of G6PD in metabolic reprogramming and redox signaling in cancer.
format Online
Article
Text
id pubmed-8358196
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Chang Gung University
record_format MEDLINE/PubMed
spelling pubmed-83581962021-08-17 G6PD: A hub for metabolic reprogramming and redox signaling in cancer Yang, Hung-Chi Stern, Arnold Chiu, Daniel Tsun-Yee Biomed J Short Review Metabolic hubs play a major role in the initiation and development of cancer. Oncogenic signaling pathways drive metabolic reprogramming and alter redox homeostasis. G6PD has potential oncogenic activity and it plays a pivotal role in cell proliferation, survival and stress responses. Aberrant activation of G6PD via metabolic reprogramming alters NADPH levels, leading to an antioxidant or a pro-oxidant environment which can either enhance DNA oxidative damage and genomic instability or initiate oncogenic signaling. Nutrient deprivation can rewire metabolism, which leads to mutations that determine a cancer cell's fate. Deregulated G6PD status and oxidative stress form a vicious cycle, which paves the way for cancer progression. This review aims to update and focus the potential role of G6PD in metabolic reprogramming and redox signaling in cancer. Chang Gung University 2021-06 2020-08-07 /pmc/articles/PMC8358196/ /pubmed/33097441 http://dx.doi.org/10.1016/j.bj.2020.08.001 Text en © 2021 Chang Gung University. Publishing services by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Short Review
Yang, Hung-Chi
Stern, Arnold
Chiu, Daniel Tsun-Yee
G6PD: A hub for metabolic reprogramming and redox signaling in cancer
title G6PD: A hub for metabolic reprogramming and redox signaling in cancer
title_full G6PD: A hub for metabolic reprogramming and redox signaling in cancer
title_fullStr G6PD: A hub for metabolic reprogramming and redox signaling in cancer
title_full_unstemmed G6PD: A hub for metabolic reprogramming and redox signaling in cancer
title_short G6PD: A hub for metabolic reprogramming and redox signaling in cancer
title_sort g6pd: a hub for metabolic reprogramming and redox signaling in cancer
topic Short Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358196/
https://www.ncbi.nlm.nih.gov/pubmed/33097441
http://dx.doi.org/10.1016/j.bj.2020.08.001
work_keys_str_mv AT yanghungchi g6pdahubformetabolicreprogrammingandredoxsignalingincancer
AT sternarnold g6pdahubformetabolicreprogrammingandredoxsignalingincancer
AT chiudanieltsunyee g6pdahubformetabolicreprogrammingandredoxsignalingincancer